Literature DB >> 24061515

The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma.

Elizabeth Euscher1, Patricia Fox, Roland Bassett, Hayma Al-Ghawi, Rouba Ali-Fehmi, Denise Barbuto, Bojana Djordjevic, Elizabeth Frauenhoffer, Insun Kim, Sun Rang Hong, Delia Montiel, Elizabeth Moschiano, Andres Roma, Elvio Silva, Anais Malpica.   

Abstract

The purpose of this study was to examine predictors of lymph node (LN) metastases or extrauterine disease (ED) in low-grade (FIGO grade 1 or 2) endometrioid carcinoma (LGEC) in a multi-institutional setting. For LGEC with and without LN metastasis or ED, each of the 9 participating institutions evaluated patients' age, tumor size, myometrial invasion (MI), FIGO grade, % solid component, the presence or absence of papillary architecture, microcystic, elongated, and fragmented glands (MELF), single-cell/cell-cluster invasion (SCI), lymphovascular invasion (LVI), lower uterine segment (LUS) and cervical stromal (CX) involvement, and numbers of pelvic and para-aortic LNs sampled. A total of 304 cases were reviewed: LN(+) or ED(+), 96; LN(-)/ED(-), 208. Patients' ages ranged from 23 to 91 years (median 61 y). Table 1 summarizes the histopathologic variables that were noted for the LN(+) or ED(+) group: tumor size ≥2 cm, 93/96 (97%); MI>50%, 54/96 (56%); MELF, 67/96 (70%); SCI, 33/96 (34%); LVI, 79/96 (82%); >20% solid, 65/96 (68%); papillary architecture present, 68/96 (72%); LUS involved, 64/96 (67%); and CX involved, 41/96 (43%). For the LN(-)/ED(-) group, the results were as follows: tumor size ≥2 cm, 152/208 (73%); MI>50%, 56/208 (27%); MELF, 79/208 (38%); SCI, 19/208 (9%); LVI, 56/208 (27%); >20% solid, 160/208 (77%); papillary architecture present, 122/208 (59%); LUS involved, 77/208 (37%); CX involved, 24/208 (12%). There was no evidence of a difference in the number of pelvic or para-aortic LNs sampled between groups (P=0.9 and 0.1, respectively). After multivariate analysis, the depth of MI, CX involvement, LVI, and SCI emerged as significant predictors of advanced-stage disease. Although univariate analysis pointed to LUS involvement, MELF pattern of invasion, and papillary architecture as possible predictors of advanced-stage disease, these were not shown to be significant by multivariate analysis. This study validates MI, CX involvement, and LVI as significant predictors of LN(+) or ED(+). The association of SCI pattern with advanced-stage LGEC is a novel finding.

Entities:  

Mesh:

Year:  2013        PMID: 24061515      PMCID: PMC3805760          DOI: 10.1097/PAS.0b013e318299f2ab

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  39 in total

1.  Adenocarcinoma of the endometrium: its metastatic lymph node potential. A preliminary report.

Authors:  W T Creasman; R C Boronow; C P Morrow; P J DiSaia; J Blessing
Journal:  Gynecol Oncol       Date:  1976-09       Impact factor: 5.482

2.  Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study.

Authors:  W T Creasman; C P Morrow; B N Bundy; H D Homesley; J E Graham; P B Heller
Journal:  Cancer       Date:  1987-10-15       Impact factor: 6.860

3.  A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis.

Authors:  S F Lax; R J Kurman; E S Pizer; L Wu; B M Ronnett
Journal:  Am J Surg Pathol       Date:  2000-09       Impact factor: 6.394

4.  Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium.

Authors:  J R Lurain; B L Rice; A W Rademaker; L E Poggensee; J C Schink; D S Miller
Journal:  Obstet Gynecol       Date:  1991-07       Impact factor: 7.661

5.  Long-term outcome in endometrial carcinoma favors a two- instead of a three-tiered grading system.

Authors:  Astrid N Scholten; Carien L Creutzberg; Evert M Noordijk; Vincent T H B M Smit
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-03-15       Impact factor: 7.038

6.  Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer.

Authors:  Michael Frumovitz; Brian M Slomovitz; Diljeet K Singh; Russell R Broaddus; Jacki Abrams; Charlotte C Sun; Michael Bevers; Diane C Bodurka
Journal:  J Am Coll Surg       Date:  2004-09       Impact factor: 6.113

7.  Significance of papillary (villoglandular) differentiation in endometrioid carcinoma of the uterus.

Authors:  R A Ambros; F Ballouk; J H Malfetano; J S Ross
Journal:  Am J Surg Pathol       Date:  1994-06       Impact factor: 6.394

8.  Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance.

Authors:  Shawn K Murray; Robert H Young; Robert E Scully
Journal:  Int J Gynecol Pathol       Date:  2003-10       Impact factor: 2.762

9.  Traditional and nontraditional histopathologic predictors of recurrence in uterine endometrioid adenocarcinoma.

Authors:  K R Lee; P M Vacek; J L Belinson
Journal:  Gynecol Oncol       Date:  1994-07       Impact factor: 5.482

10.  Diffusely infiltrating adenocarcinoma of the endometrium. A subtype with poor prognosis.

Authors:  K R Mittal; K W Barwick
Journal:  Am J Surg Pathol       Date:  1988-10       Impact factor: 6.394

View more
  18 in total

1.  Fertility-Sparing Treatment of Endometrial Cancer with Initial Infiltration of Myometrium by Resectoscopic Surgery: A Pilot Study.

Authors:  Paolo Casadio; Francesca Guasina; Roberto Paradisi; Concetta Leggieri; Giacomo Caprara; Renato Seracchioli
Journal:  Oncologist       Date:  2018-01-09

2.  The Microcystic, Elongated, and Fragmented (MELF) Pattern of Invasion: A Single Institution Report of 464 Consecutive FIGO Grade 1 Endometrial Endometrioid Adenocarcinomas.

Authors:  Amy S Joehlin-Price; Kelsey E McHugh; Julie A Stephens; Zaibo Li; Floor J Backes; David E Cohn; David W Cohen; Adrian A Suarez
Journal:  Am J Surg Pathol       Date:  2017-01       Impact factor: 6.394

Review 3.  Practical issues related to uterine pathology: staging, frozen section, artifacts, and Lynch syndrome.

Authors:  Robert A Soslow
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

Review 4.  How to approach the many faces of endometrioid carcinoma.

Authors:  Anais Malpica
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

Review 5.  [Metastatic mechanisms of uterine malignancies and therapeutic consequences].

Authors:  S F Lax; K F Tamussino; P F Lang
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

6.  Association between Morphological Patterns of Myometrial Invasion and Cancer Stem Cell Markers in Endometrial Endometrioid Carcinoma.

Authors:  Ji Y Park; Daegy Hong; Ji Young Park
Journal:  Pathol Oncol Res       Date:  2017-10-08       Impact factor: 3.201

7.  Characterization of cytoplasmic cyclin D1 as a marker of invasiveness in cancer.

Authors:  Noel P Fusté; Esmeralda Castelblanco; Isidre Felip; Maria Santacana; Rita Fernández-Hernández; Sònia Gatius; Neus Pedraza; Judit Pallarés; Tània Cemeli; Joan Valls; Marc Tarres; Francisco Ferrezuelo; Xavier Dolcet; Xavier Matias-Guiu; Eloi Garí
Journal:  Oncotarget       Date:  2016-05-10

8.  Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma.

Authors:  Sabina Sanegre; Núria Eritja; Carlos de Andrea; Juan Diaz-Martin; Ángel Diaz-Lagares; María Amalia Jácome; Carmen Salguero-Aranda; David García Ros; Ben Davidson; Rafel Lopez; Ignacio Melero; Samuel Navarro; Santiago Ramon Y Cajal; Enrique de Alava; Xavier Matias-Guiu; Rosa Noguera
Journal:  Front Cell Dev Biol       Date:  2021-06-03

9.  Microcystic, elongated, and fragmented pattern of invasion in relation to histopathologic and clinical prognostic factors in endometrioid endometrial adenocarcinoma.

Authors:  M Murat Naki; Gülbin Oran; Seza Ümit Tetikkurt; Cavide Fatma Sönmez; İlknur Türkmen; Faruk Köse
Journal:  J Turk Ger Gynecol Assoc       Date:  2017-09-01

10.  Promoter-level transcriptome in primary lesions of endometrial cancer identified biomarkers associated with lymph node metastasis.

Authors:  Emiko Yoshida; Yasuhisa Terao; Noriko Hayashi; Kaoru Mogushi; Atsushi Arakawa; Yuji Tanaka; Yosuke Ito; Hiroko Ohmiya; Yoshihide Hayashizaki; Satoru Takeda; Masayoshi Itoh; Hideya Kawaji
Journal:  Sci Rep       Date:  2017-10-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.